Commitments

9 Months Ended

Sep. 30, 2015

Commitments.

Commitments

9. Commitments

In June 2015, we entered into a contract with a third party for up to $3.8 million in clinical manufacturing supplies to support our ongoing clinical trials for ganaxolone.  Delivery is expected to begin in December 2015 and continue into 2016.  In July 2015, we paid $1.0 million of this commitment, which is recorded in prepaid expenses and other current assets as of September 30, 2015.The balance is due in 2016..